Lauxera Capital Partners

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€520m

Latest public closing

19 May 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Paris-based growth equity and buyout firm focused on healthtech.

Focus: Growth equity and buyouts in commercial-stage healthtech companies, including medical devices, digital health, healthcare software, diagnostics and life-science tools

19 May 2026: Lauxera Capital Partners closed Lauxera Growth II at €520m, above its €500m hard cap (company press release).